Silencing of uPAR via RNA interference inhibits invasion and migration of oral tongue squamous cell carcinoma
- 6 July 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (3) , 3983-3991
Abstract
Overexpression of urokinase‑type plasminogen activator receptor (uPAR) has been implicated in promoting tumor invasion in various cancer types, including oral tongue squamous cell carcinoma (OTSCC); therefore, the effect of suppressing uPAR expression on the invasive and metastatic potential of OTSCC was investigated. A total of 65 paraffin‑embedded tissues were obtained from patients with OTSCC. Immunohistochemistry was used to determine the expression level of uPAR. The Ts cells transfected with short hairpin RNA targeting uPAR were constructed and validated. The cells were used in a number of in vitro analyses, including migration, invasion and western blot analysis assays. Furthermore, a mouse lung metastatic model was used to detect the metastatic ability of OTSCC cells in the lungs. OTSCC cell metastasis and relapse were determined to be associated with uPAR immunopositivity. Inhibition of uPAR expression in Ts cells demonstrated a 40% decrease in migration and a 60% decrease in invasion in vitro, with an associated downregulation of matrix metalloprotease (MMP)‑2, MMP‑9 and phosphorylated extracellular signal‑regulated kinase. In vivo analysis indicated a 90% decrease in the number of mice bearing macroscopic lung metastases. In conclusion, the present study demonstrated that the targeting of uPAR‑inhibited cellular proliferation and invasion would provide a potential treatment for OTSCC in the future.Keywords
This publication has 36 references indexed in Scilit:
- Regulatory networks defining EMT during cancer initiation and progressionNature Reviews Cancer, 2013
- Role of Urokinase Receptor in Tumor Progression and DevelopmentTheranostics, 2013
- Apoptosis Induced by Knockdown of uPAR and MMP-9 is Mediated by Inactivation of EGFR/STAT3 Signaling in MedulloblastomaPLOS ONE, 2012
- Western blot: Technique, theory, and trouble shootingNorth American Journal of Medical Sciences, 2012
- RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and TherapyDermatology Research and Practice, 2011
- NID2 and HOXA9 Promoter Hypermethylation as Biomarkers for Prevention and Early Detection in Oral Cavity Squamous Cell Carcinoma Tissues and SalivaCancer Prevention Research, 2011
- MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair SignalsMolecular Cancer Therapeutics, 2011
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradationNature Cell Biology, 2008
- Metastasis of squamous cell carcinoma of the oral tongueCancer and Metastasis Reviews, 2007
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005